Hope Through Innovation

Our products work in partnership with and improve life.

Where health innovation matters most

Help for the Head and Heart

At LivaNova, we create breakthrough treatments for many conditions affecting the head and heart. All of our work is destined to become a part of patients in some way. And those patients are our driving force, every day.

About Us

Transforming lives, one innovation at a time

Our therapeutic areas are united by the resolve to improve and sustain quality of life.

Advanced Circulatory Support

For people in emergency cardiac or respiratory situations — we create a simpler path to rescue, recovery and beyond.

Learn More
Cardiopulmonary

For people who need short- or long-term perfusion support — we offer a full suite of systems that act as heart and/or lungs.

Learn More
Difficult-to-Treat Depression

For people suffering from depression that is difficult to treat — we offer Symmetry™, which has been shown to significantly improve lives.

Learn More
Drug-Resistant Epilepsy

For people whose epilepsy cannot be controlled using medication alone — our VNS Therapy® System offers the hope of a life not dictated by seizures.

Learn More
Heart Failure

For people whose hearts can’t pump enough blood — we make VITARIA®, which could fix the heart by balancing the brain.

Learn More
Obstructive Sleep Apnea

For people whose airflow decreases during sleep despite an effort to breathe - we offer the freedom to sleep.

Learn More
LifeSPARC System
Woman hiking and laughing
Symmetry VNS Therapy for Treatment-Resistant Depression
Epilepsy patient image
Man smiling
THN Sleep Therapy for the treatment of Obstructive Sleep Apnea (OSA)

United in mission

Our passion for providing hope for patients and their families, as well as our dedication to living out our values, unites all of us at LivaNova.
Learn Who We Are
Health Innovations

LivaNova News & Events

LivaNova at the Baird 2021 Global Healthcare Conference

See Event

LivaNova to Present at the Baird 2021 Global Healthcare Conference

Read News

LivaNova Announces Early Retirement of $450 Million Term Loan and Executes $125 Million Revolving Credit Facility

Read News